Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-26

Clinical Trial Update: The Impact of Artemether-Lumefantrine on Genes Associated With Antimalarial Resistance

View source ↗

Summary

The completed trial update analyzes how artemether-lumefantrine affects genes associated with antimalarial resistance in falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemether-lumefantrine (artemether and lumefantrine)

Snippet

Sponsor: Tropical Medicine Research Institute | Conditions: Falciparum Malaria, Antimalarials | Status: COMPLETED